Scientists are developing a way to counter ulcerative colitis
Scientists from 34 countries with an IKBFU researcher among them are working on a medicine for the treatment of ulcerative colitis.
Oct 28, 2019
0
2
Scientists from 34 countries with an IKBFU researcher among them are working on a medicine for the treatment of ulcerative colitis.
Oct 28, 2019
0
2
The largest study ever to look at why an expensive and commonly used group of drugs fails some patients with Crohn's disease has identified a genetic marker which could individualise drug treatment.
Oct 7, 2019
0
663
(HealthDay)—Electronic cigarette use has been associated with severe pulmonary illness, according to three studies published online Sept. 6 in the U.S. Centers for Disease Control and Prevention Morbidity and Mortality ...
Sep 10, 2019
0
1
Authorities say nine students from a Florida charter school ate marijuana-infused candy and were hospitalized with stomach pains.
Sep 9, 2019
0
3
Irritable bowel syndrome (IBS) is a common gastrointestinal disorder affecting 10 to 20 percent of people. Abdominal pain, bloating and altered bowel habit significantly affect patient's quality of life and can force them ...
Sep 4, 2019
0
1
In an analysis of information on 10,463 UK patients diagnosed with colorectal cancer from 2006 to 2013, patients under the age of 50 years were more likely to initially experience non-specific symptoms before being referred ...
Aug 7, 2019
0
1
Children afflicted with medical emergencies during commercial airline trips tend to have common ailments such as vomiting, fever or allergic reactions—events that should be easily treated, according to a study led by Duke ...
Jul 25, 2019
0
0
Requiring prospective bariatric surgery patients to lose weight before they can undergo the procedure may not be necessary or safe, University of Pennsylvania researchers found in a new study published recently in the journal ...
Jul 10, 2019
0
1
A team of researchers led by Duke-NUS Medical School and National Heart Centre Singapore (NHCS) found that deactivating the interleukin 11 (IL11) protein with therapeutic antibodies reverses inflammation and scarring of the ...
May 23, 2019
0
226
(HealthDay)—Avelumab (BAVENCIO) was approved this week for first-line treatment of advanced renal cell carcinoma (RCC) in combination with axitinib, the U.S. Food and Drug Administration announced.
May 17, 2019
0
0